Dairy product consumption was associated with a lower likelihood of non-alcoholic fatty liver disease: A systematic review and meta-analysis

Wei Dai, Huiyuan Liu, Tingjing Zhang, Qing Chang, Yuhong Zhao, Chuanji Guo, Yang XiaFrontiers in Nutrition 2023 · DOI

This systematic review and meta-analysis, published in Frontiers in Nutrition, synthesizes data from over 51,000 participants to investigate the controversial link between dairy consumption and non-alcoholic fatty liver disease (NAFLD). The researchers found that higher intake of dairy—specifically milk and yogurt—is associated with a lower likelihood of developing NAFLD, particularly among Asian populations and women.

TL;DR

A meta-analysis of 14 observational studies suggests that dairy consumption is inversely associated with the risk of non-alcoholic fatty liver disease (OR=0.97). The protective effect is most significant for yogurt and milk, while no noteworthy association was found for cheese or ice cream.

What Problem Does This Paper Address?

Non-alcoholic fatty liver disease (NAFLD) is a global epidemic, affecting roughly 25% of the adult population. Characterized by excessive fat accumulation in the liver (steatosis) in the absence of heavy alcohol use, it is a primary driver of chronic liver disease.

While dietary intervention is the cornerstone of NAFLD management, the role of dairy has been a point of intense debate. Some researchers argue that the saturated fats in dairy could exacerbate liver fat, while others suggest that dairy’s unique micronutrients (like calcium) and probiotics (in fermented products) might be protective. This paper seeks to resolve these conflicting findings by pooling data from multiple international studies to provide a clearer statistical picture.

Methods

The authors performed a systematic search of PubMed, Web of Science, and Scopus for studies published through early 2023. They utilized:

  • Random-effects models: To estimate combined odds ratios (ORs) and 95% confidence intervals (CIs), accounting for expected variations between different study designs.
  • Subgroup Analysis & Meta-regression: To identify "hidden" variables that might influence the results, such as geographic region, sex, BMI, and the specific type of dairy consumed.
  • Quality Assessment: Studies were vetted using the Newcastle-Ottawa scale and the Agency for Healthcare Research and Quality (AHRQ) standards to ensure only high-quality data influenced the final results.

Datasets

The meta-analysis synthesized data from 14 unique articles (comprising 25 effect groups), totaling 51,476 participants and 14,546 confirmed NAFLD cases.

  • Study Designs: Seven cross-sectional studies, six case-control studies, and one cohort study.
  • Geography: Primarily focused on Asian (9 studies) and European (4 studies) populations.
  • Diagnosis: NAFLD was confirmed via various methods, including ultrasound, MRI, and fatty liver index scores.

Key Insights and Ideas

  • The "Yogurt Advantage": Yogurt showed the strongest inverse association with NAFLD (OR=0.89). The authors hypothesize this is due to probiotics, which may inhibit inflammatory signaling pathways (like the LPS/TLR4 pathway) that contribute to liver damage.
  • Regional Disparities: The protective effect was significant in Asian populations but not in European ones. This may be due to different consumption patterns; for instance, Europeans typically consume more cheese, which has a higher saturated fat content and showed no protective benefit in this study.
  • The BMI Paradox: Interestingly, the inverse association was strongest in individuals with a "normal" BMI (18.5–24.9 kg/m²). This suggests that dairy might be more effective as a preventive measure in metabolically healthy individuals rather than a corrective intervention for those with existing obesity-related metabolic dysfunction.
  • Sex-Specific Benefits: The association was significant for women but not for men. The authors suggest that estrogen (estradiol) may play a synergistic role by inhibiting lipid accumulation and liver fibrosis.

Key Results

  • Overall Association: Dairy consumption was associated with a 3% lower likelihood of NAFLD (OR=0.97, 95% CI=0.94–0.99).
  • Product Specifics:
    • Yogurt: OR = 0.89 (Significant)
    • Milk: OR = 0.94 (Significant)
    • Cheese/Ice Cream: No significant association.
  • Subgroup Highlights: The lower likelihood was most pronounced in Asian populations (OR=0.90) and those whose intake was assessed via Food Frequency Questionnaires (FFQ).

Limitations and Future Work

  • Causality: As a meta-analysis of observational studies, this paper can show association but cannot prove that dairy causes a reduction in NAFLD risk.
  • Data Gaps: There is a notable lack of data from American populations, limiting the global generalizability of the findings.
  • Diagnostic Tools: Most included studies relied on ultrasonography rather than the "gold standard" of liver biopsy, which may lead to some misclassification of NAFLD status.
  • Future Directions: The authors call for more large-scale prospective cohort studies and randomized controlled trials (RCTs) to confirm these findings and explore the specific molecular mechanisms of dairy-derived fatty acids and probiotics.

Summary updated

Abstract

Our meta-analysis findings revealed that dairy product consumption is inversely associated with NAFLD. Consumption of dairy products could help prevent the development of non-alcoholic fatty liver disease.
BibTeX
@inproceedings{dai2023dairy,
  author = {Wei Dai and Huiyuan Liu and Tingjing Zhang and Qing Chang and Yuhong Zhao and Chuanji Guo and Yang Xia},
  title = {{Dairy product consumption was associated with a lower likelihood of non-alcoholic fatty liver disease: A systematic review and meta-analysis}},
  booktitle = {Frontiers in Nutrition},
  year = {2023},
  doi = {10.3389/fnut.2023.1119118},
}
Figure